Recent advances in biomarker detection of oral squamous cell carcinoma
Oral squamous cell carcinoma is among the most prevalent tumours of the oral and maxillofacial region. The initial symptoms are typically minor and may remain misdiagnosed until the disease advances, resulting in a significantly reduced five-year survival rate for patients. Early detection is critic...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1597086/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849423137609875456 |
|---|---|
| author | Lan Liu Xiaowu Zhong Yue Zhong Lihua Li |
| author_facet | Lan Liu Xiaowu Zhong Yue Zhong Lihua Li |
| author_sort | Lan Liu |
| collection | DOAJ |
| description | Oral squamous cell carcinoma is among the most prevalent tumours of the oral and maxillofacial region. The initial symptoms are typically minor and may remain misdiagnosed until the disease advances, resulting in a significantly reduced five-year survival rate for patients. Early detection is critical, as it can improve five-year survival rates from below 50% to 70–90%. Due to their reduced sensitivity and intrusive nature, conventional screening methods such as serological testing and histopathological biopsies have limitations in their application. In contrast, emerging technologies including single-cell sequencing, spatial transcriptomics, nanopore sequencing, biosensor technology, and artificial intelligence, among other advanced detection methods, are redefining biomarker discovery. Scalability obstacles still exist, including clinical validation gaps, high implementation costs, and analytical complexity. In order to close the gap between invention and equitable implementation, future efforts should focus on multicenter validation of potential biomarkers and cost-effective integration of these technologies. This will ultimately improve patient prognosis and quality of life. This work aims to comprehensively investigate and evaluate the prospective applications and future developmental potential of these technologies while offering an extensive examination of oral squamous cell cancer biomarker research |
| format | Article |
| id | doaj-art-a90acbf5593e4910a85dd5a3aa21bf38 |
| institution | Kabale University |
| issn | 2234-943X |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj-art-a90acbf5593e4910a85dd5a3aa21bf382025-08-20T03:30:45ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-06-011510.3389/fonc.2025.15970861597086Recent advances in biomarker detection of oral squamous cell carcinomaLan Liu0Xiaowu Zhong1Yue Zhong2Lihua Li3Department of Stomatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, ChinaDepartment of Clinical Laboratory, Affiliated Hospital of North Sichuan Medical College, Nanchong, ChinaDepartment of Stomatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, ChinaDepartment of Stomatology, Affiliated Hospital of North Sichuan Medical College, Nanchong, ChinaOral squamous cell carcinoma is among the most prevalent tumours of the oral and maxillofacial region. The initial symptoms are typically minor and may remain misdiagnosed until the disease advances, resulting in a significantly reduced five-year survival rate for patients. Early detection is critical, as it can improve five-year survival rates from below 50% to 70–90%. Due to their reduced sensitivity and intrusive nature, conventional screening methods such as serological testing and histopathological biopsies have limitations in their application. In contrast, emerging technologies including single-cell sequencing, spatial transcriptomics, nanopore sequencing, biosensor technology, and artificial intelligence, among other advanced detection methods, are redefining biomarker discovery. Scalability obstacles still exist, including clinical validation gaps, high implementation costs, and analytical complexity. In order to close the gap between invention and equitable implementation, future efforts should focus on multicenter validation of potential biomarkers and cost-effective integration of these technologies. This will ultimately improve patient prognosis and quality of life. This work aims to comprehensively investigate and evaluate the prospective applications and future developmental potential of these technologies while offering an extensive examination of oral squamous cell cancer biomarker researchhttps://www.frontiersin.org/articles/10.3389/fonc.2025.1597086/fulloral squamous cell carcinomasingle-cell sequencing technologyspatial transcriptomicsnanopore sequencingartificial intelligence technologybiosensor technology |
| spellingShingle | Lan Liu Xiaowu Zhong Yue Zhong Lihua Li Recent advances in biomarker detection of oral squamous cell carcinoma Frontiers in Oncology oral squamous cell carcinoma single-cell sequencing technology spatial transcriptomics nanopore sequencing artificial intelligence technology biosensor technology |
| title | Recent advances in biomarker detection of oral squamous cell carcinoma |
| title_full | Recent advances in biomarker detection of oral squamous cell carcinoma |
| title_fullStr | Recent advances in biomarker detection of oral squamous cell carcinoma |
| title_full_unstemmed | Recent advances in biomarker detection of oral squamous cell carcinoma |
| title_short | Recent advances in biomarker detection of oral squamous cell carcinoma |
| title_sort | recent advances in biomarker detection of oral squamous cell carcinoma |
| topic | oral squamous cell carcinoma single-cell sequencing technology spatial transcriptomics nanopore sequencing artificial intelligence technology biosensor technology |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2025.1597086/full |
| work_keys_str_mv | AT lanliu recentadvancesinbiomarkerdetectionoforalsquamouscellcarcinoma AT xiaowuzhong recentadvancesinbiomarkerdetectionoforalsquamouscellcarcinoma AT yuezhong recentadvancesinbiomarkerdetectionoforalsquamouscellcarcinoma AT lihuali recentadvancesinbiomarkerdetectionoforalsquamouscellcarcinoma |